Interspecies interactions within oral microbial communities - PubMed (original) (raw)
Review
Interspecies interactions within oral microbial communities
Howard K Kuramitsu et al. Microbiol Mol Biol Rev. 2007 Dec.
Abstract
While reductionism has greatly advanced microbiology in the past 400 years, assembly of smaller pieces just could not explain the whole! Modern microbiologists are learning "system thinking" and "holism." Such an approach is changing our understanding of microbial physiology and our ability to diagnose/treat microbial infections. This review uses oral microbial communities as a focal point to describe this new trend. With the common name "dental plaque," oral microbial communities are some of the most complex microbial floras in the human body, consisting of more than 700 different bacterial species. For a very long time, oral microbiologists endeavored to use reductionism to identify the key genes or key pathogens responsible for oral microbial pathogenesis. The limitations of reductionism forced scientists to begin adopting new strategies using emerging concepts such as interspecies interaction, microbial community, biofilms, polymicrobial disease, etc. These new research directions indicate that the whole is much more than the simple sum of its parts, since the interactions between different parts resulted in many new physiological functions which cannot be observed with individual components. This review describes some of these interesting interspecies-interaction scenarios.
Figures
FIG. 1.
Evolution of microbiological studies. Initial reductionism included zooming in from complex multispecies microbial communities to isolated genes from individual species. This process was followed by an expansion of scope based on the knowledge acquired through reductionism to achieve a holistic view of the interactions of different bacterial species and the multispecies communities in which they reside.
FIG. 2.
Oral bacteria observed by Anton van Leeuwenhoek and their contemporary equivalents. (a) The original drawings by van Leeuwenhoek. The bacterium designated A was later suggested to be a rod-shaped motile bacterium such as Campylobacter rectus (b) (photo courtesy: National Research Council Canada); the highly motile species shown in his original drawing as B and moving quickly from C to D was likely Selenomonas sputigena (c) (electron micrograph, modified from reference with permission) (187), whereas E was proposed to be oral cocci (d) (atomic force microscopy image). van Leeuwenhoek's original drawing G was disputed as being either a Spirillum sp. (not shown) or an oral spirochete such as Treponema denticola (e) (electron micrograph), and the long fusiform species designated F were proposed to be Leptotrichia (Leptotrix) buccalis (f) (electron micrograph, modified from reference with permission).
FIG. 3.
Illustration of interspecies interactions between Streptococcus mutans and selected oral streptococci that have been studied on a molecular level. (a) Interactions of S. mutans with S. gordonii, S. oligofermentans, and S. sanguinis. Depicted is the production of lactic acid, mutacin, and CSP, which also enhances mutacin production by S. mutans. Lactic acid has been found to inhibit proliferation of a variety of acid-sensitive anaerobe species, but it was recently discovered to serve as a substrate for S. oligofermentans for H2O2 production. This compound is also generated by S. sanguinis and was previously shown to inhibit growth of S. mutans. S. sanguinis and S. gordonii are sensitive to the mutacins produced by S. mutans. In contrast to S. sanguinis, which can inhibit S. mutans by its ability to produce H2O2, S. gordonii utilizes challisin to reduce mutacin production by reducing the levels of the stimulating factor CSP. The dashed arrow in combination with + indicates stimulation, solid arrows symbolize production, and ⊣ in combination with − designates inhibition. The shaded area indicates the timing-sensitive interactions between S. mutans and S. sanguinis illustrated in panel b. (b) Importance of timing for reciprocal inhibition of S. mutans (Sm) and S. sanguinis (Ss). Given a 1-day growth advantage, S. mutans inhibits S. sanguinis via its mutacin production (upper panel), whereas S. sanguinis controls establishment of S. mutans by its ability to generate H2O2 when given the same 1-day advantage (middle panel). Without the benefit to either of establishing itself earlier, both species coexist without any apparent mutual inhibition (lower panel). For further details, see the text.
Similar articles
- Oral microbiology: past, present and future.
He XS, Shi WY. He XS, et al. Int J Oral Sci. 2009 Jun;1(2):47-58. doi: 10.4248/ijos.09029. Int J Oral Sci. 2009. PMID: 20687296 Free PMC article. Review. - Short-Chain _N_-Acylhomoserine Lactone Quorum-Sensing Molecules Promote Periodontal Pathogens in In Vitro Oral Biofilms.
Muras A, Mayer C, Otero-Casal P, Exterkate RAM, Brandt BW, Crielaard W, Otero A, Krom BP. Muras A, et al. Appl Environ Microbiol. 2020 Jan 21;86(3):e01941-19. doi: 10.1128/AEM.01941-19. Print 2020 Jan 21. Appl Environ Microbiol. 2020. PMID: 31757829 Free PMC article. - Oral microbial communities in sickness and in health.
Jenkinson HF, Lamont RJ. Jenkinson HF, et al. Trends Microbiol. 2005 Dec;13(12):589-95. doi: 10.1016/j.tim.2005.09.006. Epub 2005 Oct 7. Trends Microbiol. 2005. PMID: 16214341 Review. - Microbial differences between dental plaque and historic dental calculus are related to oral biofilm maturation stage.
Velsko IM, Fellows Yates JA, Aron F, Hagan RW, Frantz LAF, Loe L, Martinez JBR, Chaves E, Gosden C, Larson G, Warinner C. Velsko IM, et al. Microbiome. 2019 Jul 6;7(1):102. doi: 10.1186/s40168-019-0717-3. Microbiome. 2019. PMID: 31279340 Free PMC article. - [Streptococcus mutans and oral streptococci in dental plaque].
Nicolas GG, Lavoie MC. Nicolas GG, et al. Can J Microbiol. 2011 Jan;57(1):1-20. doi: 10.1139/w10-095. Can J Microbiol. 2011. PMID: 21217792 Review. French.
Cited by
- The Oral Microbiome of Peri-Implant Health and Disease: A Narrative Review.
de Campos Kajimoto N, de Paiva Buischi Y, Mohamadzadeh M, Loomer P. de Campos Kajimoto N, et al. Dent J (Basel). 2024 Sep 24;12(10):299. doi: 10.3390/dj12100299. Dent J (Basel). 2024. PMID: 39452426 Free PMC article. Review. - Phenotypic heterogeneity of genomically-diverse isolates of Streptococcus mutans.
Palmer SR, Miller JH, Abranches J, Zeng L, Lefebure T, Richards VP, Lemos JA, Stanhope MJ, Burne RA. Palmer SR, et al. PLoS One. 2013 Apr 16;8(4):e61358. doi: 10.1371/journal.pone.0061358. Print 2013. PLoS One. 2013. PMID: 23613838 Free PMC article. - Biotic Interactions Shape the Ecological Distributions of Staphylococcus Species.
Kastman EK, Kamelamela N, Norville JW, Cosetta CM, Dutton RJ, Wolfe BE. Kastman EK, et al. mBio. 2016 Oct 18;7(5):e01157-16. doi: 10.1128/mBio.01157-16. mBio. 2016. PMID: 27795388 Free PMC article. - Small molecule natural products in human nasal/oral microbiota.
Barber CC, Zhang W. Barber CC, et al. J Ind Microbiol Biotechnol. 2021 Jun 4;48(3-4):kuab010. doi: 10.1093/jimb/kuab010. J Ind Microbiol Biotechnol. 2021. PMID: 33945611 Free PMC article. Review. - Lactoferrin and oral diseases: current status and perspective in periodontitis.
Berlutti F, Pilloni A, Pietropaoli M, Polimeni A, Valenti P. Berlutti F, et al. Ann Stomatol (Roma). 2011 Mar;2(3-4):10-8. Epub 2012 Jan 27. Ann Stomatol (Roma). 2011. PMID: 22545184 Free PMC article.
References
- Apolonio, A. C. M., M. A. R. Carvalho, R. N. R. Ribas, L. G. Sousa-Gaia, K. V. Santos, M. A. Lana, J. R. Nicoli, and L. M. Farias. 2007. Production of antagonistic substance by Eikenella corrodens isolated from the oral cavity of human beings with and without periodontal disease. J. Appl. Microbiol. 103:245-251. - PubMed
- Barlaan, E. A., M. Sugimori, S. Furukawa, and K. Takeuchi. 2005. Profiling and monitoring of microbial populations by denaturing high-performance liquid chromatography. J. Microbiol. Methods 61:399-412. - PubMed
- Bassler, B. L. 2002. Small talk. Cell-to-cell communication in bacteria. Cell 109:421-424. - PubMed
Publication types
MeSH terms
Grants and funding
- MD01831/MD/NIMHD NIH HHS/United States
- R01 GM054666/GM/NIGMS NIH HHS/United States
- R41 MD001831/MD/NIMHD NIH HHS/United States
- DE09821/DE/NIDCR NIH HHS/United States
- R01 DE009821/DE/NIDCR NIH HHS/United States
- R01 DE003258/DE/NIDCR NIH HHS/United States
- GM54666/GM/NIGMS NIH HHS/United States
- DE03258/DE/NIDCR NIH HHS/United States
- R42 MD001831/MD/NIMHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Miscellaneous